tetano
Editor, Senior Moderator
Open Forum Infect Dis
. 2021 Mar 26;8(7)
fab151.
doi: 10.1093/ofid/ofab151. eCollection 2021 Jul.
Establishing a Distribution Network for COVID-19 Monoclonal Antibody Therapy Across a Large Health System During a Global Pandemic
J Ryan Bariola[SUP] 1 [/SUP], Erin K McCreary[SUP] 1 [/SUP], Tina Khadem[SUP] 1 [/SUP], Graham M Snyder[SUP] 1 [/SUP], Richard J Wadas[SUP] 2 [/SUP], David A Nace[SUP] 3 [/SUP], Douglas B White[SUP] 4 [/SUP], Donald M Yealy[SUP] 2 [/SUP], Mark Schmidhofer[SUP] 5 [/SUP]
Affiliations
Abstract
Emergency authorized coronavirus disease 2019 (COVID-19)-neutralizing monoclonal antibodies can aid outpatients with mild to moderate COVID-19 infection. Many report barriers to adequate distribution and uptake. We present our model for distribution in a large health system as well as early lessons learned.
Keywords: COVID-19; COVID-19 therapies; monoclonal antibodies.
. 2021 Mar 26;8(7)
fab151.doi: 10.1093/ofid/ofab151. eCollection 2021 Jul.
Establishing a Distribution Network for COVID-19 Monoclonal Antibody Therapy Across a Large Health System During a Global Pandemic
J Ryan Bariola[SUP] 1 [/SUP], Erin K McCreary[SUP] 1 [/SUP], Tina Khadem[SUP] 1 [/SUP], Graham M Snyder[SUP] 1 [/SUP], Richard J Wadas[SUP] 2 [/SUP], David A Nace[SUP] 3 [/SUP], Douglas B White[SUP] 4 [/SUP], Donald M Yealy[SUP] 2 [/SUP], Mark Schmidhofer[SUP] 5 [/SUP]
Affiliations
- PMID: 34322560
- PMCID: PMC8083628
- DOI: 10.1093/ofid/ofab151
Abstract
Emergency authorized coronavirus disease 2019 (COVID-19)-neutralizing monoclonal antibodies can aid outpatients with mild to moderate COVID-19 infection. Many report barriers to adequate distribution and uptake. We present our model for distribution in a large health system as well as early lessons learned.
Keywords: COVID-19; COVID-19 therapies; monoclonal antibodies.